China Traditional Chinese Medicine Holdings Co. Limited Stock price
Equities
570
HK0000056256
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.28 HKD | -0.47% | -1.38% | +8.91% |
Sales 2023 | 18.12B 2.51B 19.62B | Sales 2024 * | 22.64B 3.13B 24.51B | Capitalization | 20B 2.77B 21.65B |
---|---|---|---|---|---|
Net income 2023 | 1.28B 178M 1.39B | Net income 2024 * | 1.43B 197M 1.54B | EV / Sales 2023 | 0.99 x |
Net Debt 2023 * | 1.24B 172M 1.35B | Net Debt 2024 * | 1.88B 260M 2.04B | EV / Sales 2024 * | 0.97 x |
P/E ratio 2023 |
14
x | P/E ratio 2024 * |
14
x | Employees | 17,303 |
Yield 2023 * |
1.89% | Yield 2024 * |
2.9% | Free-Float | 67.54% |
1 day | -0.47% | ||
1 week | -1.38% | ||
Current month | -0.93% | ||
1 month | -0.93% | ||
3 months | +9.18% | ||
6 months | +18.89% | ||
Current year | +8.91% |
Managers | Title | Age | Since |
---|---|---|---|
Li Xin Shen
DFI | Director of Finance/CFO | 58 | 21-09-02 |
Guoqiang Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Xue Ren Cheng
BRD | Director/Board Member | 60 | 18-12-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rong Xie
BRD | Director/Board Member | 71 | 13-02-04 |
Tze Shan Yu
BRD | Director/Board Member | 67 | 13-11-24 |
Qing Xin Meng
BRD | Director/Board Member | 50 | 22-11-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 2 M€ | -16.04% | - | |
0.06% | 11 M€ | +1.76% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4.28 | -0.47% | 36 330 074 |
24-03-27 | 4.3 | -0.23% | 21,256,000 |
24-03-26 | 4.31 | 0.00% | 24,489,000 |
24-03-25 | 4.31 | -0.23% | 27,097,600 |
24-03-22 | 4.32 | -0.46% | 22,963,000 |
Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.91% | 2.77B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.62% | 210B | |
+0.95% | 210B | |
-6.75% | 201B | |
-3.51% | 157B |